REQUEST A DEMO
Total
USD $0.00
Search more companies

Yung Shin Pharm. Ind. Co., Ltd. (Taiwan, China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Yung Shin Pharm. Ind. Co., Ltd. Profile Updated: October 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Chinese Download a sample report

Established in 1965, Yung Shin Pharmaceutical Industrial Co., Ltd manufactures and markets approximately 700 products, including human drugs, veterinary drugs, cosmeceutical products, health supplements, active pharmaceutical Ingredients, and fine chemicals.Its main products are human drugs and veterinary drugs. Recently, Yungshin has its main market from domestic market. Its products also are sold to North America, South-East Asia, Japan, and Mid-East.

Headquarters
No.1191,Section 1, Chung Shan Road, Tachia
Taichung City; Taichung City;

Contact Details: Purchase the Yung Shin Pharm. Ind. Co., Ltd. report to view the information.

Website: http://www.ysp.com.tw

Basic Information
Total Employees:
Purchase the Yung Shin Pharm. Ind. Co., Ltd. report to view the information.
Outstanding Shares:
Purchase the Yung Shin Pharm. Ind. Co., Ltd. report to view the information.
Financial Auditors:
Purchase the Yung Shin Pharm. Ind. Co., Ltd. report to view the information.
Incorporation Date:
August 26, 1965
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
永甲興業股份有限公司
73.5%
Company Performance
Financial values in the chart are available after Yung Shin Pharm. Ind. Co., Ltd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TWD. Absolute financial data is included in the purchased report.
Net sales revenue
4.67%
Total operating revenue
4.91%
Operating profit (EBIT)
6.31%
EBITDA
0.35%
Net Profit (Loss) for the Period
6.96%
Total assets
0.74%
Total equity
5.6%
Operating Profit Margin (ROS)
0.26%
Net Profit Margin
0.29%
Return on Equity (ROE)
0.11%
Debt to Equity Ratio
-5.84%
Quick Ratio
-0.01%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?